**FR0010221234 - Common Stock **

Overall **ETL** gets a fundamental rating of **4** out of 10. We evaluated **ETL** against 21 industry peers in the **Media** industry. **ETL** has a medium profitability rating, but doesn't score so well on its financial health evaluation. **ETL** is cheap, but on the other hand it scores bad on growth

The Piotroski-F score of **ETL** is **5.00**. This is a neutral score and indicates average health and profitability for **ETL**.

ROA (1.65%) VS Industry: 18% outperformed.

0.33

27.69

ROE (4.25%) VS Industry: 21% outperformed.

2.42

41.76

Profit Margin (10.12%) VS Industry: 81% outperformed.

0.46

90.00

With a **Price/Earnings Ratio** of **11.97**, the valuation of **ETL** can be described as very reasonable.

The **Forward Price/Earnings Ratio** of **7.18** indicates a rather cheap valuation of **ETL**.

When comparing the current price to the book value of **ETL**, it is valued rather cheaply. It is trading at **0.54** times its book value.

Compared to an average industry price book ratio of 1.45, **ETL** is valued rather cheaply

When comparing the **Enterprise Value to EBITDA** ratio of **ETL** to the average industry ratio of 5.79, **ETL** is valued in line with its industry peers.

Price/Earnings (11.97) VS Industry: 35% outperformed.

113.91

2.17

Price/Book (0.54) VS Industry: 76% outperformed.

6.34

0.19

Enterprise Value/ EBITDA (5.49) VS Industry: 52% outperformed.

16.87

1.09

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Measured over the past 5 years, **ETL** shows a decrease in **Earnings Per Share**. The EPS has been decreasing by **-7.90%** on average per year.

The **Earnings Per Share** is expected to grow by **5.32%** on average over the next 5 years.

The **Revenue** has decreased by **-2.07%** in the past year.

The **Revenue** has been decreasing by **-4.87%** on average over the past 5 years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | -7.9% | -11.79% | -52.81% | 17.15% | -8.82% | -5.11% | 5.32% |

Revenue | -4.87% | -4.47% | -2.07% | -1.21% | 1.11% | 2.6% | -0.47% |

The Current Ratio is in line with the industry averages, which is at **1.03**.

The Piotroski-F score of **ETL** is **5.00**. This is a neutral score and indicates average health and profitability for **ETL**.

When comparing the Debt to Equity Ratio of **ETL** to the average industry Debt to Equity Ratio of **0.54**, **ETL** required more debt to finance its operations than its industry peers.

When comparing the Altman-Z score of **ETL** to the average industry Altman-Z score of **1.32**, **ETL** is less financially healthy than its industry peers.

Debt/Equity (1.15) VS Industry: 23% outperformed.

4.23

0.09

Quick Ratio (1.02) VS Industry: 57% outperformed.

0.41

1.68

Current Ratio (1.03) VS Industry: 52% outperformed.

0.42

2.05

Altman-Z (0.85) VS Industry: 23% outperformed.

-3.18

3.79

With a **Yearly Dividend Yield** of **15.41%**, **ETL** is a good candidate for dividend investing.

The dividend of **ETL** decreases each year by **-9.87%**.

The **Dividend Rate** of **ETL** has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

Dividend Yield (15.41%) VS Industry: 100% outperformed.

0.44

15.41

EPA:ETL (3/29/2023, 9:53:04 AM)**0 (0%) **

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap1.49B

Analysts54.44

Price Target8.94 (49.37%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 15.41% |

Dividend Growth(5Y)-9.87%

DP69.07%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)-62.65%

Min EPS beat(2)-62.65%

Max EPS beat(2)-62.65%

EPS beat(4)N/A

Avg EPS beat(4)-60.25%

Min EPS beat(4)-62.65%

Max EPS beat(4)-57.85%

Revenue beat(2)N/A

Avg Revenue beat(2)-0.32%

Min Revenue beat(2)-0.32%

Max Revenue beat(2)-0.32%

Revenue beat(4)1

Avg Revenue beat(4)0.06%

Min Revenue beat(4)-0.32%

Max Revenue beat(4)0.44%

PT rev (1m)-8.54%

PT rev (3m)-12.98%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-9.95%

EPS NY rev (3m)-9.95%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-1.63%

Revenue NY rev (3m)-1.63%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.97 | ||

Fwd PE | 7.18 | ||

P/S | 1.29 | ||

P/FCF | 2.8 | ||

P/OCF | 1.88 | ||

P/B | 0.54 | ||

P/tB | 1.33 | ||

EV/EBITDA | 5.49 |

EPS(TTM)0.5

EY8.35%

EPS(NY)0.83

Fwd EY13.92%

FCF(TTM)2.13

FCFY35.66%

OCF(TTM)3.18

OCFY53.17%

SpS4.64

BVpS11.04

TBVpS4.51

PEG (NY)0.7

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 1.65% | ||

ROE | 4.25% | ||

ROIC | 4.19% | ||

ROICexc | 4.45% | ||

ROICexgc | 6.09% | ||

OM | 26.27% | ||

PM | 10.12% | ||

GM | 95.1% |

ROICexgc(3y)9.27%

ROICexcg growth 3Y-11.92%

ROICexcg growth 5Y-2.6%

ROICexc(3y)6.51%

ROICexc growth 3Y-9.78%

ROICexc growth 5Y-3.32%

OM growth 3Y-2.52%

OM growth 5Y-2.38%

PM growth 3Y-8.03%

PM growth 5Y-3.38%

GM growth 3Y-0.22%

GM growth 5Y0.41%

F-Score5

Asset Turnover0.16

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.15 | ||

Debt/FCF | 6.16 | ||

Debt/EBITDA | 4.16 | ||

Cap/Depr | 54.11% | ||

Profit Quality | 454.67% | ||

Current Ratio | 1.03 | ||

Quick Ratio | 1.02 | ||

Altman-Z | 0.85 |

F-Score5

WACC5.71%

ROIC/WACC1.07

Cap/Depr(3y)36.96%

Cap/Depr(5y)41.08%

Profit Quality(3y)262.5%

Profit Quality(5y)234.88%

Growth

EPS 1Y-52.81%

EPS 3Y-11.79%

EPS 5Y-7.9%

EPS growth Q2Q-70.18%

EPS Next Y17.15%

EPS Next 2Y-8.82%

EPS Next 3Y-5.11%

EPS Next 5Y5.32%

Revenue growth 1Y-2.07%

Revenue growth 3Y-4.47%

Revenue growth 5Y-4.87%

Revenue growth Q2Q0.28%

Revenue Next Year-1.21%

Revenue Next 2Y1.11%

Revenue Next 3Y2.6%

Revenue Next 5Y-0.47%

EBIT growth 1Y-28.86%

EBIT growth 3Y-6.88%

EBIT growth 5Y-7.13%

EBIT Next Year72.76%

EBIT Next 3Y20.02%

EBIT Next 5Y9.94%

FCF growth 1Y-24.57%

FCF growth 3Y-0.72%

FCF growth 5Y1.12%

OCF growth 1Y-5.82%

OCF growth 3Y-1.89%

OCF growth 5Y-4.01%

*Find stocks with similar Fundamental rating on the EuroNext*

*Find the competitors with the best fundamentals on the EuroNext*

*Find the competitors with the best valuation on the EuroNext*

*Find the competitors with the best dividend on the EuroNext*